Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-06 8:46 pm Purchase | 2026-05-04 | 13D | GYRE THERAPEUTICS INC GYRE | GNI Group Ltd. | 86,323,015 69.100% | 13,009,130 (+17.74%) | Filing History |
| 2024-01-24 5:11 pm Unchanged | 2024-01-22 | 13D | GYRE THERAPEUTICS INC GYRE | GNI Group Ltd. | 73,313,885 85.340% | 0 (Unchanged) | Filing History |
| 2023-11-27 4:49 pm Unchanged | 2023-11-22 | 13D | GYRE THERAPEUTICS INC GYRE | GNI Group Ltd. | 73,313,885 85.360% | 0 (Unchanged) | Filing History |
| 2023-11-01 4:58 pm Purchase | 2023-10-30 | 13D | GYRE THERAPEUTICS INC GYRE | GNI Group Ltd. | 73,313,885 85.360% | 67,047,364 (+1069.93%) | Filing History |
| 2023-10-30 7:28 pm Unchanged | 2023-10-27 | 13D | CATALYST BIOSCIENCES INC N CBIO | GNI Group Ltd. | 62,665 16.500% | 0 (Unchanged) | Filing History |
| 2023-01-04 6:13 pm Purchase | 2022-12-26 | 13D | CATALYST BIOSCIENCES INC N CBIO | GNI Group Ltd. | 62,665 16.600% | 62,665 (New Position) | Filing History |